valproic acid has been researched along with Acquired Nephrogenic Diabetes Insipidus in 3 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This hypernatremia was due to renal diabetes insipidus stemming from the decades of lithium therapy, with accompanying polydipsia and polyuria, and also to the failure to give enough fluid to the somnolent patient." | 1.31 | [Hypernatremia as a rare complication in change from lithium to valproate]. ( Berendes, K; Glass, W; Warmke, C, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Damba, JJ | 1 |
| Bodenstein, K | 1 |
| Lavin, P | 1 |
| Drury, J | 1 |
| Sekhon, H | 1 |
| Renoux, C | 1 |
| Trinh, E | 1 |
| Rej, S | 1 |
| Greenway, KT | 1 |
| Berendes, K | 2 |
| Glass, W | 1 |
| Warmke, C | 1 |
1 review available for valproic acid and Acquired Nephrogenic Diabetes Insipidus
| Article | Year |
|---|---|
Psychotropic Drugs and Adverse Kidney Effects: A Systematic Review of the Past Decade of Research.
Topics: Aged; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Diabetes Insipi | 2022 |
2 other studies available for valproic acid and Acquired Nephrogenic Diabetes Insipidus
| Article | Year |
|---|---|
[Hypo- and hypernatremia].
Topics: Anticonvulsants; Antimanic Agents; Carbamazepine; Diabetes Insipidus, Nephrogenic; Humans; Hypernatr | 2011 |
[Hypernatremia as a rare complication in change from lithium to valproate].
Topics: Antimanic Agents; Bipolar Disorder; Diabetes Insipidus, Nephrogenic; Drug Therapy, Combination; Fema | 2001 |